VUZE Medical

Software-only Guidance Solution for Spinal Surgery

Health Tech & Life Sciences
Non Active, May 2026 ceased to operate

Company Overview

Snapshot

Founded in March 2017 by David Tolkowsky, VUZE Medical operated with 1–10 employees. The company received FDA 510(k) clearance for its VUZE System in January 2022, a significant milestone for its software-only guidance solution for skeletal surgery.

Business overview

VUZE Medical developed VUZE, a software-only intra-operative guidance solution specifically designed for skeletal surgery, with a primary focus on spinal procedures. The company's core technology utilizes proprietary dynamic online image fusion software to automatically overlay surgical tool positions from 2D X-rays onto a pre-surgery 3D scan in real time. This solution aims to improve accuracy and reduce radiation exposure compared to traditional X-ray guidance, targeting growing market segments in the health tech and life sciences sectors, particularly within digital healthcare and medical decision support for healthcare providers.

Strategic signal

In October 2023, VUZE Medical showcased its next-generation software-based guidance system for spine surgery at NASS 2023, following an FDA filing. This event signaled the company's continued development and regulatory progress, indicating a strategic push towards market readiness and adoption of its technology in the surgical guidance landscape.

Company Intelligence Q&A

What is VUZE Medical's primary product?
VUZE Medical's primary product is VUZE, a software-only intra-operative guidance solution for skeletal surgery, with a focus on spinal procedures.
When was VUZE Medical founded?
VUZE Medical was founded in March 2017.
What was a key regulatory milestone for VUZE Medical?
In January 2022, VUZE Medical announced U.S. FDA 510(k) clearance for its VUZE System.
What was a recent development regarding VUZE Medical's technology?
In October 2023, VUZE Medical showcased its next-generation software-based guidance system for spine surgery at NASS 2023, following an FDA filing.
What was the outcome of a clinical study for the VUZE Surgical Guidance System?
In May 2023, the VUZE Surgical Guidance System showed promise in a clinical study.

External links